Bank Of New York Mellon Corp Syros Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

  • $528 Trillion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.69 - $1.21 $113,071 - $198,285
-163,872 Reduced 86.1%
26,447 $25,000
Q1 2022

May 11, 2022
SELL
$1.02 - $3.8 $3,800 - $14,158
-3,726 Reduced 1.92%
190,319 $227,000
Q4 2021

Feb 11, 2022
SELL
$3.26 - $4.66 $6,846 - $9,786
-2,100 Reduced 1.07%
194,045 $633,000
Q3 2021

Nov 12, 2021
BUY
$4.08 - $5.66 $37,939 - $52,632
9,299 Added 4.98%
196,145 $876,000
Q2 2021

Aug 11, 2021
BUY
$5.01 - $7.48 $197,839 - $295,377
39,489 Added 26.8%
186,846 $1.02 Million
Q1 2021

May 13, 2021
BUY
$7.19 - $14.95 $80,643 - $167,679
11,216 Added 8.24%
147,357 $1.1 Million
Q4 2020

Feb 09, 2021
SELL
$6.66 - $14.66 $52,933 - $116,517
-7,948 Reduced 5.52%
136,141 $1.48 Million
Q3 2020

Nov 12, 2020
SELL
$8.69 - $14.47 $43,093 - $71,756
-4,959 Reduced 3.33%
144,089 $1.27 Million
Q2 2020

Aug 12, 2020
BUY
$5.21 - $11.03 $168,199 - $356,092
32,284 Added 27.65%
149,048 $1.59 Million
Q1 2020

May 06, 2020
BUY
$4.46 - $9.2 $24,088 - $49,689
5,401 Added 4.85%
116,764 $692,000
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $461 - $1,030
-102 Reduced 0.09%
111,363 $769,000
Q3 2019

Nov 07, 2019
BUY
$7.14 - $11.65 $39,676 - $64,739
5,557 Added 5.25%
111,465 $1.16 Million
Q2 2019

Aug 12, 2019
BUY
$5.5 - $9.75 $124,619 - $220,915
22,658 Added 27.22%
105,908 $981,000
Q1 2019

May 14, 2019
SELL
$5.51 - $9.59 $7,091 - $12,342
-1,287 Reduced 1.52%
83,250 $761,000
Q4 2018

Feb 11, 2019
BUY
$5.55 - $11.34 $38,200 - $78,053
6,883 Added 8.86%
84,537 $470,000
Q3 2018

Nov 09, 2018
BUY
$9.74 - $12.92 $68,783 - $91,241
7,062 Added 10.0%
77,654 $0
Q2 2018

Aug 06, 2018
BUY
$10.16 - $13.65 $193,090 - $259,418
19,005 Added 36.84%
70,592 $720,000
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $155,004 - $212,456
16,368 Added 46.47%
51,587 $670,000
Q4 2017

Feb 09, 2018
BUY
$8.45 - $17.48 $297,600 - $615,628
35,219
35,219 $343,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email